Doctor of Podiatric Medicine Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Curtis Wagner

Podiatrist Orlando, FL Doctor of Podiatric Medicine

NPI 1972615037 CMS profile 89215

7350 Sandlake Commons Blvd, Suite 3329, Orlando, FL 32819

Open in the dashboard

General payments

$5,461

113 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Curtis Wagner of Orlando, FL is reported in the CMS Open Payments database as having received $5,461 across 113 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 84th percentile of Podiatrist profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $290 14
2024 General $174 5
2023 General $253 7
2022 General $349 15
2021 General $3,396 39
2020 General $350 16
2019 General $648 17

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Curtis Wagner
  • Podiatrist median
  • Middle half of Podiatrist
  • National median

In program year 2025, general payments to Curtis Wagner were reported at $290. Among 4,572 Podiatrist profiles paid that year, the median was $260 and the middle half received between $94 and $777.

Show as a table
Year Curtis Wagner Podiatrist median Middle half National median
2019 $648 $196 $72–$601 $163
2020 $350 $118 $38–$335 $114
2021 $3,396 $169 $57–$573 $132
2022 $349 $220 $74–$782 $149
2023 $253 $208 $71–$635 $160
2024 $174 $237 $87–$681 $164
2025 $290 $260 $94–$777 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Arthrex, Inc. $2,944 21 payments
  2. Stryker Corporation $522 11 payments
  3. Horizon Therapeutics plc $473 21 payments
  4. Smith+Nephew, Inc. $306 9 payments
  5. Curonix LLC $163 5 payments
  6. Paragon 28, Inc. $115 2 payments
  7. Paratek Pharmaceuticals, Inc. $113 7 payments
  8. Dynasplint Systems Inc. $103 1 payment
  9. Organogenesis Inc. $79 3 payments
  10. Globus Medical, Inc. $65 3 payments
  11. Other $578 30 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $2,662 105 payments
  2. Education $2,400 2 payments
  3. Travel and Lodging $399 6 payments
Products named General payments · program years 2019–2025
  1. 7 X 23MM CITRELOCK IMPLANT $186 2 payments
  2. CITREFIX $186 2 payments
  3. DUEXIS $182 8 payments
  4. PENNSAID $167 8 payments
  5. PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A $163 5 payments
  6. PROPHECY $156 1 payment
  7. GRAFIX XC $125 1 payment
  8. Grafix CORE $125 1 payment
  9. Grafix PL PRIME $125 1 payment
  10. Grafix PRIME $125 1 payment
  11. Other $2,503 88 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 16 drugs

Part D claims

651

Median for Podiatry: 160

Drug cost

$10,437

Median for Podiatry: $2,368

Branded share of claims

14%

Median for Podiatry: 12.7%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Pregabalin Generic 53 $2,056
Gabapentin Generic 96 $1,790
Colchicine Generic 15 $1,400
Ketoconazole Generic 55 $1,133
Ciclopirox Generic 23 $668
Mupirocin Generic 93 $657
Celecoxib Generic 29 $373
Methylprednisolone Generic 37 $362
Allopurinol Generic 33 $352
Tramadol Hcl Generic 57 $346

The 10 drugs with the highest cost, of 16 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 14,093 Part D prescribers listed as Podiatry; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 36 billing codes

Paid by Medicare

$201,437

Of which drugs: $302

Medicare patients

835

Average age 77

Services billed

3,927

490 women, 345 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 64%
Ischemic heart disease 38%
Diabetes 36%
Chronic kidney disease 32%
Heart failure 23%
Atrial fibrillation 22%
Osteoporosis 20%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 205 407 $302

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

1 product · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
NUZYRA
  • Paratek Pharmaceuticals, Inc. $13
$13 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

113 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Podiatrist in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record